<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0010">
 <label>10</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0010">
  <string-name>
   <surname>Olsen</surname>
   <given-names>EA</given-names>
  </string-name>, 
  <string-name>
   <surname>Kim</surname>
   <given-names>YH</given-names>
  </string-name>, 
  <string-name>
   <surname>Kuzel</surname>
   <given-names>TM</given-names>
  </string-name>, et al. 
  <article-title>Phase IIb multicentre trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T‐cell lymphoma</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2007</year>;
  <volume>25</volume>:
  <fpage>3109</fpage>‐
  <lpage>3115</lpage>.
  <pub-id pub-id-type="pmid">17577020</pub-id>
 </mixed-citation>
</ref>
